Trial record 1 of 17 for:    Open Studies | "Learning Disorders"
Previous Study | Return to List | Next Study

Risk and Resilience Factors in Learning Disabilities Population

The recruitment status of this study is unknown because the information has not been verified recently.
Verified June 2012 by Rabin Medical Center.
Recruitment status was  Recruiting
Sponsor:
Information provided by (Responsible Party):
Rabin Medical Center
ClinicalTrials.gov Identifier:
NCT01652651
First received: June 17, 2012
Last updated: July 25, 2012
Last verified: June 2012
  Purpose

The purpose of this study is to report preliminary outcomes of executive function and psychopathology symptoms of a manual-based psychological intervention for adolescents diagnosed with learning disorders- I can succeed (ICS).


Condition Intervention
Learning Disorders
Behavioral: I Can Succeed ICS

Study Type: Interventional
Study Design: Intervention Model: Single Group Assignment
Masking: Open Label
Primary Purpose: Supportive Care
Official Title: The Contribution of Risk and Resilience Factors in Learning Disabilities Population to Academic and Emotional Development

Resource links provided by NLM:


Further study details as provided by Rabin Medical Center:

Primary Outcome Measures:
  • Change in Child Behavior Checklist (CBCL) (Achenbach, 1991). [ Time Frame: base line (time 0) and end of treatment (3 month) ] [ Designated as safety issue: No ]
    The Child Behavior Checklist (CBCL) is a device by which parents and teachers rate a child's problem behaviors and competencies. It consists of 112 behavioral items (and 1 open-ended item) scored on a 3-step response scale from Not true (0) to Very true or Often true (2). Subscales include Aggressive Behavior, Anxious/Depressed, Attention Problems, Delinquent Rule-Breaking Behavior, Social Problems, Somatic Complaints, Thought Problems, Withdrawn, Externalizing, Internalizing, Total Problems, plus DSM-oriented scales.


Secondary Outcome Measures:
  • Change in The standardized Brain Resource cognition assessment, ''IntegNeuro,'' (Clark et al., 2006). [ Time Frame: base line (time 0) and end of treatment (3 month) ] [ Designated as safety issue: No ]
    A computerized standardized assessment of Executive Functions and Continuous Performance Test


Estimated Enrollment: 70
Study Start Date: May 2009
Estimated Study Completion Date: December 2013
Primary Completion Date: April 2012 (Final data collection date for primary outcome measure)
Arms Assigned Interventions
Experimental: Psychological Intervention Behavioral: I Can Succeed ICS
ICS is a manual-based psychological intervention aimed to address both emotional and academic-executive functions aspects of LD.It consists of acute phase (13 once a week sessions) and follow-up phase (6 sessions over 18 months). ICS focuses on developing intrapersonal skills (e.g. self awareness, goal setting, organizational skills), interpersonal skills (e.g. communication, problem solving)and school/community skills (i.e. strengthening the family-school relationship) (Kopelman-Rubin et al., 2011).

  Eligibility

Ages Eligible for Study:   11 Years to 15 Years
Genders Eligible for Study:   Both
Accepts Healthy Volunteers:   Yes
Criteria

Inclusion Criteria:

  • Learning Disorder diagnosis
  • Normal range IQ
  • Regular class attendance

Exclusion Criteria:

  • Suicidal ideation and psychosis
  Contacts and Locations
Choosing to participate in a study is an important personal decision. Talk with your doctor and family members or friends about deciding to join a study. To learn more about this study, you or your doctor may contact the study research staff using the Contacts provided below. For general information, see Learn About Clinical Studies.

Please refer to this study by its ClinicalTrials.gov identifier: NCT01652651

Contacts
Contact: Daphne Kopelman-Rubin, Ph.D +972-9-9549497 daphnekr@idc.ac.il

Locations
Israel
Schneider Children Medical Center of Israel Recruiting
Petah Tikva, Israel, 49202
Contact: Daphne Kopelman-Rubin, Ph.D    +972-9-9549497    Daphnekr@idc.ac.il   
Sponsors and Collaborators
Rabin Medical Center
Investigators
Principal Investigator: Daphne Kopelman-Rubin, Ph.D Schneider's Children Medical Center of Israel
  More Information

No publications provided

Responsible Party: Rabin Medical Center
ClinicalTrials.gov Identifier: NCT01652651     History of Changes
Other Study ID Numbers: 5383
Study First Received: June 17, 2012
Last Updated: July 25, 2012
Health Authority: Israel: Ethics Commission

Keywords provided by Rabin Medical Center:
Learning Disorders

Additional relevant MeSH terms:
Learning Disorders
Communication Disorders
Neurobehavioral Manifestations
Neurologic Manifestations
Nervous System Diseases
Signs and Symptoms
Mental Disorders Diagnosed in Childhood
Mental Disorders

ClinicalTrials.gov processed this record on August 21, 2014